Year in Review: Prostate Cancer - 2024 Insights and Exciting Prospec…

Jason Hafron

Year in Review - Prostate Cancer

Oncology 2024 Year in Review

K. Tawagi

Year in Review 2024 - Managing Advanced Prostate Cancer

Oncology 2024 Year in Review

R. Dreicer

Year in Review - Key Clinical Trials in Prostate Cancer

GWU Urology

Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC

Advanced Prostate Cancer Consensus Conference (APCCC)

K. Fizazi

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer

University of Illinois Cancer Center

K. Tawagi, N. Reizine

Advanced Prostate Cancer Therapy: Effective and Minimally Invasive

DrTalks

M. Hong

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Update on Systemic Treatments for Metastatic Prostate Cancer

Emmanuel Seront

Erectile Dysfunction in Patients with Prostate Cancer and Metabolic …

DrTalks

R. Valenzuela

Evolving Strategies in First and Second-Line Treatment for mCRPC

International Urology Cancer Summit - IUCS

N. Agarwal

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

Understanding PSMA PET Scans in Prostate Cancer Diagnosis

GRACE

K. Jatwani, K. Tawagi, M. Kurian

Avoiding Unnecessary Operations in Prostate Cancer

Penn Medicine Abramson Cancer Center

P. Pierorazio

Urologic Oncology: What to Look for in 2025

GWU Urology

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

ASCO® GU 2025 Insights: mCRPC Survival Outcomes With 177Lu-PSMA-617 …

Insights from 2025 ASCO® GU Annual Meeting

N. Sayegh